US2011014695A1PendingUtilityA1
Methods for obtaining adult human olfactory progenitor cells
Individually held — no corporate assignee on recordPriority: Mar 29, 2001Filed: Sep 23, 2010Published: Jan 20, 2011
Est. expiryMar 29, 2021(expired)· nominal 20-yr term from priority
C12N 5/0623A61K 35/12A61P 25/00C12N 2503/02
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An isolated human olfactory stem cell can be prepared by culturing human tissue from olfactory neuroepithelium to form neurospheres.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A primary culture, or a subculture thereof, of human olfactory neuroepithelium (ONe)-sourced cells comprising cells that are, individually, immunoreactive for both nestin and beta-tubulin isotype III.
2 . The culture of claim 1 , wherein the culture comprises neurospheres.
3 . The culture of claim 2 , wherein the neurospheres comprise cells that are each immunoreactive for both nestin and beta-tubulin isotype III.
4 . The culture of claim 1 , wherein the cells that are immunoreactive for both nestin and beta-tubulin isotype III can, under appropriate conditions, differentiate into neurons and oligodendrocytes.
5 . The culture of claim 1 , wherein the source of the cells is an adult donor.
6 . The culture of claim 1 , wherein the source of the cells is a live donor.
7 . The culture of claim 6 , wherein the live donor is afflicted with a neurological disorder.
8 . The culture of claim 1 , wherein at least some of the cells that are immunoreactive for both nestin and beta-tubulin isotype III further comprise a transgene.
9 . The culture of claim 1 , wherein the cells that are immunoreactive for both nestin and beta-tubulin isotype III double every 18-24 hours in Olfactory Epithelial Medium (OEM) at 37° C. in an atmosphere of humidified 5% CO 2 , wherein the OEM consists of 90% Minimal Essential Medium with Hanks' salts with L-glutamine and 10% FBS.
10 . The culture of claim 1 , wherein the culture comprises one or more differentiation factors.
11 . The culture of claim 10 , wherein the differentiation factor is a growth factor.
12 . The culture of claim 1 , wherein the culture comprises dibutryl cAMP.
13 . The culture of claim 1 , wherein the culture comprises about 1% to about 30% serum.
14 . The culture of claim 1 , wherein the culture is a subculture.
15 . The culture of claim 1 , wherein the culture has been passaged multiple times.
16 . The culture of claim 1 , wherein the culture has been passaged at least 200 times.
17 . The culture of claim 1 , wherein the culture is frozen.
18 . A primary culture, or a subculture thereof, of human olfactory neuroepithelium (ONe)-sourced cells comprising neurospheres, wherein the neurospheres comprise cells that are, individually, immunoreactive for both nestin and beta-tubulin isotype III.
19 . Neurospheres derived from numan olfactory neuroepithelium (ONe), wherein the neurospheres comprise cells that are, individually, immunoreactive for both nestin and beta-tubulin isotype III, or progeny of the cells that are, individually, immunoreactive for both nestin and beta-tubulin isotype III, wherein the progeny of the cells are capable of forming neurospheres.
20 . A kit, comprising:
a plurality of human ONe-sourced cells that are, individually, immunoreactive for both nestin and beta-tubulin isotype III; and instructional material, wherein the instructional material comprises text that indicates that the plurality of human ONe-sourced cells are, individually, immunoreactive for both nestin and beta-tubulin isotype III.
21 . The kit of claim 20 , wherein the plurality of cells are frozen.
22 . The kit of claim 20 , wherein the instructional material further comprises a recipe for culture media.
23 . The kit of claim 20 , wherein the instructional material further comprises instructions for re-initiating a culture of the plurality of cells.Join the waitlist — get patent alerts
Track US2011014695A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.